BioXcel Therapeutics, Inc. (BTAIQ) stock
BTAIQOTCPharmaceutical PreparationsFiscal year ends December 31
$0.03−0.00 (-13.49%)
Close on Oct 19, 2026Market cap $757.50KP/E –Yield –
BioXcel Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
BioXcel Therapeutics's market cap was $782.63K on Oct 19, 2026, against $13.57M a year earlier. Over the last 5 years it ranged from $782.63K to $898.45M, with a median of $74.05M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $782.63K | -97.6% |
| 2025 | Dec 31, 2025 | $31.99M | +101.5% |
| 2024 | Dec 31, 2024 | $15.88M | -81.6% |
| 2023 | Dec 29, 2023 | $86.36M | -85.7% |
| 2022 | Dec 30, 2022 | $601.93M | +5.8% |
| 2021 | Dec 31, 2021 | $568.83M | -49.4% |
| 2020 | Dec 31, 2020 | $1.13B | +327.0% |
| 2019 | Dec 31, 2019 | $263.49M | +336.3% |
| 2018 | Dec 31, 2018 | $60.39M | – |
See a number that looks wrong?